Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis
暂无分享,去创建一个
L. Magder | W. Mitch | S. Seliger | C. Howell | R. Christenson | J. Raufman | M. Weir | A. Opekun | J. Goss | T. Dowling | A. Rana | J. Vierling | A. L. Mindikoglu | S. Khaderi | Ayse L. Mindikoglu
[1] A. L. Mindikoglu,et al. New Developments in Hepatorenal Syndrome , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] F. Nevens,et al. Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis , 2017, Hepatology.
[3] E. Cholongitas,et al. Comparison of creatinine and cystatin formulae with 51Chromium‐ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis , 2016, Journal of Gastroenterology and Hepatology.
[4] L. Magder,et al. Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] G. Beck,et al. GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] G. Filler,et al. Beta-trace protein as a marker of GFR--history, indications, and future research. , 2014, Clinical biochemistry.
[7] L. Magder,et al. A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measurements , 2014, American Journal of Nephrology.
[8] L. Magder,et al. Performance of chronic kidney disease epidemiology collaboration creatinine‐cystatin C equation for estimating kidney function in cirrhosis , 2014, Hepatology.
[9] J. Dumortier,et al. Creatinine‐ versus cystatine C‐based equations in assessing the renal function of candidates for liver transplantation with cirrhosis , 2014, Hepatology.
[10] R. Moreau,et al. Glomerular filtration rate equations for liver‐kidney transplantation in patients with cirrhosis: Validation of current recommendations , 2014, Hepatology.
[11] L. Magder,et al. Impact of estimated liver volume and liver weight on gender disparity in liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] L. Risch,et al. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C‐based MELD better? , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[13] Harold I Feldman,et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.
[14] R. Quinn,et al. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. , 2011, Journal of hepatology.
[15] E. Vittinghoff,et al. Height Contributes to the Gender Difference in Wait‐List Mortality Under the MELD‐Based Liver Allocation System , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] L. Magder,et al. Gender disparity in liver transplant waiting‐list mortality: The importance of kidney function , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] R. Moreau,et al. Inaccuracies of creatinine and creatinine‐based equations in candidates for liver transplantation with low creatinine: Impact on the model for end‐stage liver disease score , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] L. Stevens,et al. Measured GFR as a confirmatory test for estimated GFR. , 2009, Journal of the American Society of Nephrology : JASN.
[19] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[20] Yeong-Seok Im,et al. Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List , 2009 .
[21] T. Pruett. Disparities in Liver Transplantation Before and After Introduction of the MELD Score , 2009 .
[22] E. Cavalier,et al. New Data on the Intraindividual Variation of Cystatin C , 2008, Nephron Clinical Practice.
[23] Samantha C Huo,et al. Is the Corrected-Creatinine Model for End-Stage Liver Disease a Feasible Strategy to Adjust Gender Difference in Organ Allocation for Liver Transplantation? , 2007, Transplantation.
[24] M. Petri,et al. Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft—Gault equations , 2007, Lupus.
[25] M. Heneghan,et al. Novel approaches to assessing renal function in cirrhotic liver disease , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[26] Tom Greene,et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.
[27] E. Cholongitas,et al. Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores—A Systematic Bias , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] Roger Williams,et al. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis , 2007, Hepatology.
[29] R. Swaminathan,et al. Intra-individual variation in creatinine and cystatin C , 2007, Clinical chemistry and laboratory medicine.
[30] J. Cooke,et al. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] M. Serra,et al. Accumulation of Symmetric Dimethylarginine in Hepatorenal Syndrome , 2006, Experimental biology and medicine.
[32] W Greg Miller,et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. , 2006, Clinical chemistry.
[33] L. Stevens,et al. Measurement of kidney function. , 2005, The Medical clinics of North America.
[34] R. Nijveldt,et al. The human liver clears both asymmetric and symmetric dimethylarginine , 2005, Hepatology.
[35] Arend Bkenkamp. Kidney function itself, and not cystatin C, is correlated with height and weight. , 2005 .
[36] G. Filler,et al. Cystatin C as a marker of GFR--history, indications, and future research. , 2005, Clinical biochemistry.
[37] D. Spiegelman,et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.
[38] L. Hansson,et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L , 2004, Scandinavian journal of clinical and laboratory investigation.
[39] G. Spinas,et al. Serum cystatin C is sensitive to small changes in thyroid function. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[40] S. Bachmann,et al. Impact of thyroid dysfunction on serum cystatin C. , 2003, Kidney international.
[41] D. Fish,et al. Assessing renal function in cirrhotic patients: problems and pitfalls. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[42] B. Stoffel‐Wagner,et al. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. , 2002, Clinical chemistry.
[43] R. Orlando,et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. , 2002, Clinical chemistry.
[44] H. Vilstrup,et al. Plasma cystatin C as a marker of renal function in patients with liver cirrhosis , 2002, Scandinavian journal of clinical and laboratory investigation.
[45] A. Gerbes,et al. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver , 2002, Gut.
[46] K. Jung,et al. β-Trace Protein Is Not Better than Cystatin C as an Indicator of Reduced Glomerular Filtration Rate , 2001 .
[47] L. Risch,et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. , 2001, Clinical chemistry.
[48] K. Jung,et al. Beta-trace protein is not better than cystatin C as an indicator of reduced glomerular filtration rate. , 2001, Clinical chemistry.
[49] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[50] K. Jung,et al. Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. , 1999, Clinical chemistry.
[51] I. Olafsson,et al. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. , 1995, Scandinavian journal of clinical and laboratory investigation.
[52] L. W. Statius van Eps,et al. β2-microglobulin: Its significance in the evaluation of renal function , 1987 .
[53] A. Arieff,et al. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. , 1987, The American journal of medicine.
[54] D. Cocchetto,et al. Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. , 1983, Therapeutic drug monitoring.
[55] T. Bjornsson. Use of Serum Creatinine Concentrations to Determine Renal Function1 , 1979, Clinical pharmacokinetics.
[56] W. Mitch,et al. A proposed mechanism for reduced creatinine excretion in severe chronic renal failure. , 1978, Nephron.
[57] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .
[58] J. Kassirer,et al. Clinical evaluation of kidney function--glomerular function. , 1971, The New England journal of medicine.
[59] Q. Mcnemar. Note on the sampling error of the difference between correlated proportions or percentages , 1947, Psychometrika.
[60] D. DuBois,et al. A formula to estimate the approximate surface area if height and weight be known , 1989 .
[61] D. D. Bois,et al. CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .